_id
69172a433c536f8df2316d90
Ticker
VPRO
Name
Viropro Inc
Exchange
OTCCE
Address
2151 O'Toole Avenue, San Jose, CA, United States, 95131
Country
USA
Sector
Healthcare
Industry
Biotechnology
Currency
USD
Website
https://www.viropro.net
Description
Viropro Inc., through its subsidiaries, engages in the contract research, development, and manufacture of biotherapeutic proteins for the treatment of various diseases. The company is also involved in the transfer of its proprietary technologies for industrial production of biogeneric therapeutic proteins for the treatment of various diseases, such as cancer, diabetes, hepatitis, or multiple sclerosis. It manufactures biologics drugs, including bio-similars for pre-clinical, and Phase I, II, and III clinical trials; offers its clients with supply of mammalian cell proteins, such as monoclonal antibodies or recombinant proteins, or other cell-derived products; owns three clones that include two in insulin therapy and one for cancer therapy; and provides contractual research and manufacturing services to biotech and biopharmaceutical companies. The company's contractual work activities include cloning, sequencing, purifying, developing, validating, and producing biopharmaceutical products and sub-products. It has operations in Canada, the United Kingdom, and Malaysia. Viropro Inc. has collaboration agreement with Oncobiologics, Inc. to manufacture and commercialize monoclonal antibody products. The company is based in San Jose, California. Viropro Inc. is a subsidiary of Alpha Biologics Limited.
Last Close
-
Volume
-
Current Price
-
Change
0
Last Updated
2026-01-08T12:25:52.082Z
Image
https://logo.clearbit.com/www.viropro.net
Ipo Date
-
Market Cap
18321
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
-
Sentiment Sources
0
Current Quarter
2011-09-30
Revenue
385156
Cost Of Revenue
0
Gross Profit
385156
Operating Expenses
1190369
Operating Income
-805213
Interest Expense
233600
Pretax Income
-1038813
Net Income
-1038813
Eps
-
Dividends Per Share
0
Shares Outstanding
916089570
Income Tax Expense
0
EBITDA
-
Operating Margin
-209.06152312309817
Total Other Income Expense Net
-233600
Cash
119250
Short Term Investments
0
Receivables
82702
Inventories
50631
Total Current Assets
291020
Property Plant Equipment
15607911
Total Assets
38774293
Payables
2345197
Short Term Debt
0
Long Term Debt
11908187
Total Liabilities
17618085
Equity
21156208
Bs_currency_symbol
USD
Depreciation
25997656.11
Change In Working Capital
-
Cash From Operations
321186761.04
Capital Expenditures
22177563.73
Cash From Investing
36295989.65
Cash From Financing
-445625050.62
Net Change In Cash
-67564330.17
Cf_currency_symbol
USD
PE
-
PB
-
ROE
-4.910204134880882
ROA
-2.679128153284445
FCF
299009197.31
Fcf Percent
776.3326997632129
Piotroski FScore
2
Health Score
51
Deep Value Investing Score
5
Defensive Investing Score
5
Dividend Investing Score
3
Economic Moat Investing Score
5.3
Garp Investing Score
5.5
Growth Investing Score
4.5
Momentum Investing Score
2
Net Net Investing Score
4
Quality Investing Score
4
Value Investing Score
2.5
Quarters > 0 > quarter
2011-09-30
Quarters > 0 > income Statement > revenue
385156
Quarters > 0 > income Statement > cost Of Revenue
0
Quarters > 0 > income Statement > gross Profit
385156
Quarters > 0 > income Statement > operating Expenses
1190369
Quarters > 0 > income Statement > operating Income
-805213
Quarters > 0 > income Statement > interest Expense
233600
Quarters > 0 > income Statement > pretax Income
-1038813
Quarters > 0 > income Statement > net Income
-1038813
Quarters > 0 > income Statement > eps
-
Quarters > 0 > income Statement > dividends Per Share
0
Quarters > 0 > income Statement > shares Outstanding
0
Quarters > 0 > income Statement > income Tax Expense
0
Quarters > 0 > income Statement > EBITDA
-
Quarters > 0 > income Statement > operating Margin
-209.06152312309817
Quarters > 0 > income Statement > total Other Income Expense Net
-233600
Quarters > 0 > income Statement > currency_symbol
USD
Quarters > 0 > balance Sheet > cash
119250
Quarters > 0 > balance Sheet > short Term Investments
0
Quarters > 0 > balance Sheet > receivables
82702
Quarters > 0 > balance Sheet > inventories
50631
Quarters > 0 > balance Sheet > total Current Assets
291020
Quarters > 0 > balance Sheet > property Plant Equipment
15607911
Quarters > 0 > balance Sheet > total Assets
38774293
Quarters > 0 > balance Sheet > payables
2345197
Quarters > 0 > balance Sheet > short Term Debt
0
Quarters > 0 > balance Sheet > long Term Debt
11908187
Quarters > 0 > balance Sheet > total Liabilities
17618085
Quarters > 0 > balance Sheet > equity
21156208
Quarters > 0 > balance Sheet > currency_symbol
USD
Quarters > 0 > cash Flow > net Income
-1038813
Quarters > 0 > cash Flow > depreciation
25997656.11
Quarters > 0 > cash Flow > change In Working Capital
-
Quarters > 0 > cash Flow > cash From Operations
321186761.04
Quarters > 0 > cash Flow > capital Expenditures
22177563.73
Quarters > 0 > cash Flow > cash From Investing
36295989.65
Quarters > 0 > cash Flow > cash From Financing
-445625050.62
Quarters > 0 > cash Flow > net Change In Cash
-67564330.17
Quarters > 0 > cash Flow > currency_symbol
USD
Quarters > 0 > ratios > PE
-
Quarters > 0 > ratios > PB
-
Quarters > 0 > ratios > ROE
-4.910204134880882
Quarters > 0 > ratios > ROA
-2.679128153284445
Quarters > 0 > ratios > FCF
299009197.31
Quarters > 0 > ratios > Piotroski FScore
2
Quarters > 0 > ratios > fcf Percent
776.3326997632129
Quarters > 0 > health Score
51
Quarters > 1 > quarter
2011-06-30
Quarters > 1 > income Statement > revenue
221935
Quarters > 1 > income Statement > cost Of Revenue
0
Quarters > 1 > income Statement > gross Profit
221935
Quarters > 1 > income Statement > operating Expenses
0
Quarters > 1 > income Statement > operating Income
-741741
Quarters > 1 > income Statement > interest Expense
1500
Quarters > 1 > income Statement > pretax Income
-743241
Quarters > 1 > income Statement > net Income
-743241
Quarters > 1 > income Statement > eps
-
Quarters > 1 > income Statement > dividends Per Share
-
Quarters > 1 > income Statement > shares Outstanding
-
Quarters > 1 > income Statement > income Tax Expense
0
Quarters > 1 > income Statement > EBITDA
-
Quarters > 1 > income Statement > operating Margin
-334.2154234347895
Quarters > 1 > income Statement > total Other Income Expense Net
-1500
Quarters > 1 > income Statement > currency_symbol
USD
Quarters > 1 > balance Sheet > cash
191090
Quarters > 1 > balance Sheet > short Term Investments
-
Quarters > 1 > balance Sheet > receivables
52892
Quarters > 1 > balance Sheet > inventories
-
Quarters > 1 > balance Sheet > total Current Assets
590133
Quarters > 1 > balance Sheet > property Plant Equipment
70570
Quarters > 1 > balance Sheet > total Assets
2543775
Quarters > 1 > balance Sheet > payables
649666
Quarters > 1 > balance Sheet > short Term Debt
141056
Quarters > 1 > balance Sheet > long Term Debt
-
Quarters > 1 > balance Sheet > total Liabilities
1424722
Quarters > 1 > balance Sheet > equity
1119053
Quarters > 1 > balance Sheet > currency_symbol
USD
Quarters > 1 > cash Flow > net Income
-743241
Quarters > 1 > cash Flow > depreciation
5325
Quarters > 1 > cash Flow > change In Working Capital
-
Quarters > 1 > cash Flow > cash From Operations
-526743
Quarters > 1 > cash Flow > capital Expenditures
23581
Quarters > 1 > cash Flow > cash From Investing
-38593
Quarters > 1 > cash Flow > cash From Financing
684000
Quarters > 1 > cash Flow > net Change In Cash
119414
Quarters > 1 > cash Flow > currency_symbol
USD
Quarters > 1 > ratios > PE
-
Quarters > 1 > ratios > PB
-
Quarters > 1 > ratios > ROE
-66.41696148439797
Quarters > 1 > ratios > ROA
-29.218032255211252
Quarters > 1 > ratios > FCF
-550324
Quarters > 1 > ratios > Piotroski FScore
1
Quarters > 1 > ratios > fcf Percent
-2.479662964381463
Quarters > 1 > health Score
26
Quarters > 2 > quarter
2011-03-31
Quarters > 2 > income Statement > revenue
232237
Quarters > 2 > income Statement > cost Of Revenue
0
Quarters > 2 > income Statement > gross Profit
232237
Quarters > 2 > income Statement > operating Expenses
0
Quarters > 2 > income Statement > operating Income
-324738
Quarters > 2 > income Statement > interest Expense
1500
Quarters > 2 > income Statement > pretax Income
-326238
Quarters > 2 > income Statement > net Income
-326238
Quarters > 2 > income Statement > eps
-
Quarters > 2 > income Statement > dividends Per Share
-
Quarters > 2 > income Statement > shares Outstanding
-
Quarters > 2 > income Statement > income Tax Expense
0
Quarters > 2 > income Statement > EBITDA
-
Quarters > 2 > income Statement > operating Margin
-139.83043184333246
Quarters > 2 > income Statement > total Other Income Expense Net
-1500
Quarters > 2 > income Statement > currency_symbol
USD
Quarters > 2 > balance Sheet > cash
71676
Quarters > 2 > balance Sheet > short Term Investments
-
Quarters > 2 > balance Sheet > receivables
89292
Quarters > 2 > balance Sheet > inventories
-
Quarters > 2 > balance Sheet > total Current Assets
221042
Quarters > 2 > balance Sheet > property Plant Equipment
52314
Quarters > 2 > balance Sheet > total Assets
2156428
Quarters > 2 > balance Sheet > payables
538821
Quarters > 2 > balance Sheet > short Term Debt
141056
Quarters > 2 > balance Sheet > long Term Debt
-
Quarters > 2 > balance Sheet > total Liabilities
729877
Quarters > 2 > balance Sheet > equity
1426551
Quarters > 2 > balance Sheet > currency_symbol
USD
Quarters > 2 > cash Flow > net Income
-326238
Quarters > 2 > cash Flow > depreciation
5324
Quarters > 2 > cash Flow > change In Working Capital
-
Quarters > 2 > cash Flow > cash From Operations
-192506
Quarters > 2 > cash Flow > capital Expenditures
23581
Quarters > 2 > cash Flow > cash From Investing
-38593
Quarters > 2 > cash Flow > cash From Financing
206000
Quarters > 2 > cash Flow > net Change In Cash
12744
Quarters > 2 > cash Flow > currency_symbol
USD
Quarters > 2 > ratios > PE
-
Quarters > 2 > ratios > PB
-
Quarters > 2 > ratios > ROE
-22.869003631836506
Quarters > 2 > ratios > ROA
-15.128629381551342
Quarters > 2 > ratios > FCF
-216087
Quarters > 2 > ratios > Piotroski FScore
1
Quarters > 2 > ratios > fcf Percent
-0.9304589707927677
Quarters > 2 > health Score
32
Quarters > 3 > quarter
2010-12-31
Quarters > 3 > income Statement > revenue
173818
Quarters > 3 > income Statement > cost Of Revenue
0
Quarters > 3 > income Statement > gross Profit
173818
Quarters > 3 > income Statement > operating Expenses
0
Quarters > 3 > income Statement > operating Income
-135377
Quarters > 3 > income Statement > interest Expense
13634
Quarters > 3 > income Statement > pretax Income
-136614
Quarters > 3 > income Statement > net Income
-136614
Quarters > 3 > income Statement > eps
-
Quarters > 3 > income Statement > dividends Per Share
-
Quarters > 3 > income Statement > shares Outstanding
-
Quarters > 3 > income Statement > income Tax Expense
0
Quarters > 3 > income Statement > EBITDA
-
Quarters > 3 > income Statement > operating Margin
-77.88433879114936
Quarters > 3 > income Statement > total Other Income Expense Net
-1237
Quarters > 3 > income Statement > currency_symbol
USD
Quarters > 3 > balance Sheet > cash
58932
Quarters > 3 > balance Sheet > short Term Investments
-
Quarters > 3 > balance Sheet > receivables
103904
Quarters > 3 > balance Sheet > inventories
-
Quarters > 3 > balance Sheet > total Current Assets
172836
Quarters > 3 > balance Sheet > property Plant Equipment
57638
Quarters > 3 > balance Sheet > total Assets
2113546
Quarters > 3 > balance Sheet > payables
461086
Quarters > 3 > balance Sheet > short Term Debt
175556
Quarters > 3 > balance Sheet > long Term Debt
-
Quarters > 3 > balance Sheet > total Liabilities
657089
Quarters > 3 > balance Sheet > equity
1456457
Quarters > 3 > balance Sheet > currency_symbol
USD
Quarters > 3 > cash Flow > net Income
-136614
Quarters > 3 > cash Flow > depreciation
9157
Quarters > 3 > cash Flow > change In Working Capital
-
Quarters > 3 > cash Flow > cash From Operations
58776
Quarters > 3 > cash Flow > capital Expenditures
23581
Quarters > 3 > cash Flow > cash From Investing
-38593
Quarters > 3 > cash Flow > cash From Financing
58000
Quarters > 3 > cash Flow > net Change In Cash
39066
Quarters > 3 > cash Flow > currency_symbol
USD
Quarters > 3 > ratios > PE
-
Quarters > 3 > ratios > PB
-
Quarters > 3 > ratios > ROE
-9.379885571630334
Quarters > 3 > ratios > ROA
-6.463734406537639
Quarters > 3 > ratios > FCF
35195
Quarters > 3 > ratios > Piotroski FScore
2
Quarters > 3 > ratios > fcf Percent
0.20248190636182672
Quarters > 3 > health Score
55
Annuals > 0 > quarter
2010-12-31
Annuals > 0 > income Statement > revenue
571098
Annuals > 0 > income Statement > cost Of Revenue
0
Annuals > 0 > income Statement > gross Profit
571098
Annuals > 0 > income Statement > operating Expenses
0
Annuals > 0 > income Statement > operating Income
-996515
Annuals > 0 > income Statement > interest Expense
0
Annuals > 0 > income Statement > pretax Income
-1010149
Annuals > 0 > income Statement > net Income
-1010149
Annuals > 0 > income Statement > eps
-
Annuals > 0 > income Statement > dividends Per Share
-
Annuals > 0 > income Statement > shares Outstanding
-
Annuals > 0 > income Statement > income Tax Expense
0
Annuals > 0 > income Statement > EBITDA
-
Annuals > 0 > income Statement > operating Margin
-174.49106808288596
Annuals > 0 > income Statement > total Other Income Expense Net
-13634
Annuals > 0 > income Statement > currency_symbol
USD
Annuals > 0 > balance Sheet > cash
58932
Annuals > 0 > balance Sheet > short Term Investments
-
Annuals > 0 > balance Sheet > receivables
103904
Annuals > 0 > balance Sheet > inventories
-
Annuals > 0 > balance Sheet > total Current Assets
172836
Annuals > 0 > balance Sheet > property Plant Equipment
57638
Annuals > 0 > balance Sheet > total Assets
2113546
Annuals > 0 > balance Sheet > payables
461086
Annuals > 0 > balance Sheet > short Term Debt
175556
Annuals > 0 > balance Sheet > long Term Debt
-
Annuals > 0 > balance Sheet > total Liabilities
657089
Annuals > 0 > balance Sheet > equity
1456457
Annuals > 0 > balance Sheet > currency_symbol
USD
Annuals > 0 > cash Flow > net Income
-1010149
Annuals > 0 > cash Flow > depreciation
27538
Annuals > 0 > cash Flow > change In Working Capital
-
Annuals > 0 > cash Flow > cash From Operations
-675620
Annuals > 0 > cash Flow > capital Expenditures
0
Annuals > 0 > cash Flow > cash From Investing
-
Annuals > 0 > cash Flow > cash From Financing
263025
Annuals > 0 > cash Flow > net Change In Cash
39569
Annuals > 0 > cash Flow > currency_symbol
USD
Annuals > 0 > ratios > PE
-
Annuals > 0 > ratios > PB
-
Annuals > 0 > ratios > ROE
-69.35659617825999
Annuals > 0 > ratios > ROA
-47.794039022571546
Annuals > 0 > ratios > FCF
-675620
Annuals > 0 > ratios > Piotroski FScore
1
Annuals > 0 > ratios > fcf Percent
-1.1830193767094264
Annuals > 0 > health Score
36
Annuals > 1 > quarter
2009-12-31
Annuals > 1 > income Statement > revenue
0
Annuals > 1 > income Statement > cost Of Revenue
0
Annuals > 1 > income Statement > gross Profit
0
Annuals > 1 > income Statement > operating Expenses
566724
Annuals > 1 > income Statement > operating Income
-566724
Annuals > 1 > income Statement > interest Expense
0
Annuals > 1 > income Statement > pretax Income
-566856
Annuals > 1 > income Statement > net Income
-566856
Annuals > 1 > income Statement > eps
-
Annuals > 1 > income Statement > dividends Per Share
-
Annuals > 1 > income Statement > shares Outstanding
-
Annuals > 1 > income Statement > income Tax Expense
0
Annuals > 1 > income Statement > EBITDA
-
Annuals > 1 > income Statement > operating Margin
-
Annuals > 1 > income Statement > total Other Income Expense Net
-132
Annuals > 1 > income Statement > currency_symbol
USD
Annuals > 1 > balance Sheet > cash
54775
Annuals > 1 > balance Sheet > short Term Investments
-
Annuals > 1 > balance Sheet > receivables
-
Annuals > 1 > balance Sheet > inventories
-
Annuals > 1 > balance Sheet > total Current Assets
59638
Annuals > 1 > balance Sheet > property Plant Equipment
2219
Annuals > 1 > balance Sheet > total Assets
61857
Annuals > 1 > balance Sheet > payables
130420
Annuals > 1 > balance Sheet > short Term Debt
100000
Annuals > 1 > balance Sheet > long Term Debt
-
Annuals > 1 > balance Sheet > total Liabilities
430420
Annuals > 1 > balance Sheet > equity
-368563
Annuals > 1 > balance Sheet > currency_symbol
USD
Annuals > 1 > cash Flow > net Income
-566856
Annuals > 1 > cash Flow > depreciation
27538
Annuals > 1 > cash Flow > change In Working Capital
-
Annuals > 1 > cash Flow > cash From Operations
-335292
Annuals > 1 > cash Flow > capital Expenditures
0
Annuals > 1 > cash Flow > cash From Investing
-
Annuals > 1 > cash Flow > cash From Financing
263025
Annuals > 1 > cash Flow > net Change In Cash
-424944
Annuals > 1 > cash Flow > currency_symbol
USD
Annuals > 1 > ratios > PE
-
Annuals > 1 > ratios > PB
-
Annuals > 1 > ratios > ROE
153.80165670455256
Annuals > 1 > ratios > ROA
-916.3974974538048
Annuals > 1 > ratios > FCF
-335292
Annuals > 1 > ratios > Piotroski FScore
0
Annuals > 1 > ratios > fcf Percent
-
Annuals > 1 > health Score
40
Annuals > 2 > quarter
2009-11-30
Annuals > 2 > income Statement > revenue
0
Annuals > 2 > income Statement > cost Of Revenue
0
Annuals > 2 > income Statement > gross Profit
0
Annuals > 2 > income Statement > operating Expenses
0
Annuals > 2 > income Statement > operating Income
-879513
Annuals > 2 > income Statement > interest Expense
0
Annuals > 2 > income Statement > pretax Income
-1464926
Annuals > 2 > income Statement > net Income
-1464926
Annuals > 2 > income Statement > eps
-
Annuals > 2 > income Statement > dividends Per Share
-
Annuals > 2 > income Statement > shares Outstanding
-
Annuals > 2 > income Statement > income Tax Expense
0
Annuals > 2 > income Statement > EBITDA
-
Annuals > 2 > income Statement > operating Margin
-
Annuals > 2 > income Statement > total Other Income Expense Net
51689
Annuals > 2 > income Statement > currency_symbol
USD
Annuals > 2 > balance Sheet > cash
-
Annuals > 2 > balance Sheet > short Term Investments
-
Annuals > 2 > balance Sheet > receivables
-
Annuals > 2 > balance Sheet > inventories
-
Annuals > 2 > balance Sheet > total Current Assets
-
Annuals > 2 > balance Sheet > property Plant Equipment
-
Annuals > 2 > balance Sheet > total Assets
-
Annuals > 2 > balance Sheet > payables
-
Annuals > 2 > balance Sheet > short Term Debt
-
Annuals > 2 > balance Sheet > long Term Debt
-
Annuals > 2 > balance Sheet > total Liabilities
-
Annuals > 2 > balance Sheet > equity
-
Annuals > 2 > balance Sheet > currency_symbol
-
Annuals > 2 > cash Flow > net Income
-1464926
Annuals > 2 > cash Flow > depreciation
675609
Annuals > 2 > cash Flow > change In Working Capital
-
Annuals > 2 > cash Flow > cash From Operations
-723412
Annuals > 2 > cash Flow > capital Expenditures
2448
Annuals > 2 > cash Flow > cash From Investing
892
Annuals > 2 > cash Flow > cash From Financing
790000
Annuals > 2 > cash Flow > net Change In Cash
52049
Annuals > 2 > cash Flow > currency_symbol
USD
Annuals > 2 > ratios > PE
-
Annuals > 2 > ratios > PB
-
Annuals > 2 > ratios > ROE
-
Annuals > 2 > ratios > ROA
-
Annuals > 2 > ratios > FCF
-725860
Annuals > 2 > ratios > Piotroski FScore
1
Annuals > 2 > ratios > fcf Percent
-
Annuals > 2 > health Score
38
Annuals > 3 > quarter
2008-12-31
Annuals > 3 > income Statement > revenue
0
Annuals > 3 > income Statement > cost Of Revenue
0
Annuals > 3 > income Statement > gross Profit
0
Annuals > 3 > income Statement > operating Expenses
0
Annuals > 3 > income Statement > operating Income
-852797
Annuals > 3 > income Statement > interest Expense
0
Annuals > 3 > income Statement > pretax Income
-1734615
Annuals > 3 > income Statement > net Income
-1734615
Annuals > 3 > income Statement > eps
-
Annuals > 3 > income Statement > dividends Per Share
-
Annuals > 3 > income Statement > shares Outstanding
-
Annuals > 3 > income Statement > income Tax Expense
0
Annuals > 3 > income Statement > EBITDA
-
Annuals > 3 > income Statement > operating Margin
-
Annuals > 3 > income Statement > total Other Income Expense Net
-297595
Annuals > 3 > income Statement > currency_symbol
USD
Annuals > 3 > balance Sheet > cash
2726
Annuals > 3 > balance Sheet > short Term Investments
-
Annuals > 3 > balance Sheet > receivables
2429
Annuals > 3 > balance Sheet > inventories
-
Annuals > 3 > balance Sheet > total Current Assets
129598
Annuals > 3 > balance Sheet > property Plant Equipment
-
Annuals > 3 > balance Sheet > total Assets
129598
Annuals > 3 > balance Sheet > payables
404548
Annuals > 3 > balance Sheet > short Term Debt
692169
Annuals > 3 > balance Sheet > long Term Debt
485630
Annuals > 3 > balance Sheet > total Liabilities
1582347
Annuals > 3 > balance Sheet > equity
-1452749
Annuals > 3 > balance Sheet > currency_symbol
USD
Annuals > 3 > cash Flow > net Income
-1734615
Annuals > 3 > cash Flow > depreciation
563500
Annuals > 3 > cash Flow > change In Working Capital
-
Annuals > 3 > cash Flow > cash From Operations
-872151
Annuals > 3 > cash Flow > capital Expenditures
73250
Annuals > 3 > cash Flow > cash From Investing
-25288
Annuals > 3 > cash Flow > cash From Financing
893149
Annuals > 3 > cash Flow > net Change In Cash
-37267
Annuals > 3 > cash Flow > currency_symbol
USD
Annuals > 3 > ratios > PE
-
Annuals > 3 > ratios > PB
-
Annuals > 3 > ratios > ROE
119.40225049199826
Annuals > 3 > ratios > ROA
-1338.4581552184447
Annuals > 3 > ratios > FCF
-945401
Annuals > 3 > ratios > Piotroski FScore
1
Annuals > 3 > ratios > fcf Percent
-
Annuals > 3 > health Score
41
Valuation > final Score
50
Valuation > verdict
Fair
Profitability > metrics > ROE
-4.910204134880882
Profitability > metrics > ROA
-356.95587932100887
Profitability > metrics > Net Margin
-2.6971227242987257
Profitability > final Score
0
Profitability > verdict
Weak
Risk > metrics > Debt Equity
0.8327619486441048
Risk > metrics > Interest Coverage
-3.4469734589041097
Risk > final Score
34
Risk > verdict
High
Liquidity > metrics > Current Ratio
0.12409192063609155
Liquidity > metrics > Quick Ratio
0.10250268953951416
Liquidity > final Score
15
Liquidity > verdict
Weak
Prev Valuations > 0
50
Prev Valuations > 1
50
Prev Valuations > 2
50
Prev Profitabilities > 0
0
Prev Profitabilities > 1
0
Prev Profitabilities > 2
0
Prev Risks > 0
-1948
Prev Risks > 1
-818
Prev Risks > 2
20
Prev Liquidities > 0
47
Prev Liquidities > 1
26
Prev Liquidities > 2
24
Updated At
2026-01-20T22:47:31.064Z
Earnings History > 0 > period
2011-06-30
Earnings History > 0 > report Date
2011-09-30
Earnings History > 0 > date
2011-06-30
Earnings History > 0 > before After Market
-
Earnings History > 0 > currency
USD
Earnings History > 0 > eps Actual
-0.0012
Earnings History > 0 > eps Estimate
0
Earnings History > 0 > eps Difference
-0.0012
Earnings History > 0 > surprise Percent
-
Viropro Inc., through its subsidiaries, engages in the contract research, development, and manufacture of biotherapeutic proteins for the treatment of various diseases. The company is also involved in the transfer of its proprietary technologies for industrial production of biogeneric therapeutic proteins for the treatment of various diseases, such as cancer, diabetes, hepatitis, or multiple sclerosis. It manufactures biologics drugs, including bio-similars for pre-clinical, and Phase I, II, and III clinical trials; offers its clients with supply of mammalian cell proteins, such as monoclonal antibodies or recombinant proteins, or other cell-derived products; owns three clones that include two in insulin therapy and one for cancer therapy; and provides contractual research and manufacturing services to biotech and biopharmaceutical companies. The company's contractual work activities include cloning, sequencing, purifying, developing, validating, and producing biopharmaceutical products and sub-products. It has operations in Canada, the United Kingdom, and Malaysia. Viropro Inc. has collaboration agreement with Oncobiologics, Inc. to manufacture and commercialize monoclonal antibody products. The company is based in San Jose, California. Viropro Inc. is a subsidiary of Alpha Biologics Limited.
Stock Price
$0.00
decrease compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/AIntel Stock Surges on Apple Deal Buzz: Can INTC Sustain This Momentum? TradingView — Track All Markets
Read more →Intel Rides on Strength in Client Computing Group: Will it Persist? TradingView — Track All Markets
Read more →Showing 2 of 10
(Last Updated 2011-09-30)
Health Score
Return on Equity (ROE)
-
Very Low
Low ≤ 5%
High ≥ 25%
Return on Assets (ROA)
-
Very Low
Low ≤ 2%
High ≥ 10%
Free Cash Flow - Revenue % (FCF)
-
Very High
Low ≤ 5%
High ≥ 15%
Debt to Equity
-
Low
Low ≥ 1
High ≤ 0.3
* Institutions hold a combined 0.00% of the total shares of Viropro Inc
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
Date
—
EPS Estimate
—
Date
2011-06-30
EPS Actual
-0.0012
EPS Estimate
0
EPS Difference
-0.0012
Surprise Percent
0%
(Last Updated 2011-09-30)
(Last Updated 2011-09-30)
Revenue
$ 0
Cost Of Revenue
$ 0
Gross Profit
$ 0
Operating Expenses
$ 0
Operating Income
$ 0
Interest Expense
$ 0
Pretax Income
$ 0
Net Income
$ 0
Income Tax Expense
$ 0
EBITDA
$ 0
Total Other Income Expense Net
$ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2011-09-30)
Cash
$ 0
Short Term Investments
$ 0
Receivables
$ 0
Inventories
$ 0
Total Current Assets
$ 0
Property Plant Equipment
$ 0
Total Assets
$ 0
Payables
$ 0
Short Term Debt
$ 0
Long Term Debt
$ 0
Total Liabilities
$ 0
Equity
$ 0
(Last Updated 2011-09-30)
Net Income
$ 0
Depreciation
$ 0
Change In Working Capital
$ 0
Cash From Operations
$ 0
Capital Expenditures
$ 0
Cash From Investing
$ 0
Cash From Financing
$ 0
Net Change In Cash
$ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.